Since Wnt5a was able to suppress tumor formation and alter the subtype of MMTV-Wnt1 tumors, we tested the hypothesis that Wnt5a expression in these tumors would also result in reduced Wnt/β-catenin signaling. The gene discussed is WNT1; the disease is neoplasm.